Angiogenesis, arteriogenesis, and physiological perfusion: Review of natural history and concepts

Journal of Interventional Cardiology

Volumn 12, Issue 4, 1999, Pages 313-318

  Kern, Morton J ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; RECOMBINANT GROWTH FACTOR; TRANSFORMING GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; DISEASE COURSE; DRUG MECHANISM; MOLECULAR DYNAMICS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; VASA VASORUM;

EID: 0032858523     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8183.1999.tb00251.x     Document Type: Review

References (48)

1. Schaper W, Buschmann I. Collateral circulation and diabetes. Circulation 1999;99:2224-2226.
2. Yancopoulos GD, Klagsbrun M, Folkman J. Vasculogenesis, angiogenesis and growth factors: Ephrins enter the fray at the border. Cell 1998;93:661-664.
3. Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-674.
4. Schaper W, Schaper J. Collateral Circulation. Norwell, MA: Kluwer Academic Publishers, 1993.
5. Ito W, Arras M, Scholz D, et al. Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Am J Physiol 1997;273:H-1255-H-1265.
6. Ito WD, Arras M, Winkler B, et al. Monocyte chemotactic protein-I increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 1997;80:829-837.
7. Unger EF, Sheffield CD, Epstein SE. Heparin promotes the formation of extracardaic to coronary anastomoses in a canine model. Am J Physiol 1991;260:H-1625-H-1634.
8. Eischen A, Vincent F, Bergerat JP, et al. Long-term cultures of human monocytes in vitro: Impact of GM-CSF on survival and differentiation. J Immunol Methods 1991;147:3408-3412.
9. Cavaillon JM. Cytokines and macrophages. Biomed Pharmacother 1994;48:445-453.
10. Scholz D, Ito W, Arras M, et al. Early events in adaptive arteriogenesis. J Mol Cell Cardiol 1998;30(Suppl):A127.
11. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med 1995;333:1757-1763.
12. Dvorak HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factors, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-1039.
13. Stavri GT, Hong Y, Zachary IC, et al. Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells. FEBS Lett 1995;358:311-315.
14. Nagel T, Resnick N, Atkinson WJ, et al. Shear stress selectively upregulates intercellular adhesion molecule-I expression in cultured human vascular endothelial cells. J Clin Invest 1994;94:885-891.
15. Kitayami J, Mackay C, Ponath PD, et al. The c-c-chemokine receptor (CCR3) particpates in stimulation of eosinophil arrest on inflammatory endothelium in shear flow. J Clin Invest 1998;101:2017-2024.
16. Chappell DC, Varner SE, Nerem RM, et al. Oscillatory shear stress stimulates adhesion molecule expression in cultured human endothelium. Circ Res 1998;82:532-539.
17. Abaci A, Oguzhan A, Kahraman S, et al. Effect of diabetes mellitus on the formation of coronary collateral vessels. Circulation 1999;99:2239-2242.
18. Isner JM. Cancer and atherosclerosis: The broad mandate of angiogenesis. Circulation 1999;99:1653-1655.
19. Moulton KS, Heller E, Konerding MA, et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 1999;99:1726-1732.
20. 165- Lancet 1996;348:370-374.
21. Asahara T, Bauters C, Pastore CJ, et al. Local delivery of vascular endothelial growth factor accelerates reendothelization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 1995;91:2793-2801.
22. 165 gene transfer. Circulation 1997;94:3291-3302.
23. Tsurumi Y, Murohara T, Krasinski K, et al. Reciprocal relationship between VEGF and NO in the regulation endothelial integrity. Nat Med 1997;3:879-886.
24. 165 inhibits thrombus formation and intimal thickening. J Am Coll Cardiol 1997;29:1371-1379.
25. Heistad DD, Armstrong ML, Marcus ML. Hyperemia of the aortic wall in atherosclerotic monkeys. Circ Res 1981;48:669-675.
26. Wolinsky H, Glagov S. Nature of species differences in the medial distribution of aortic vasa vasorum in mammals. Circ Res 1967;20:409.
27. Kwon HM, Sangiorgi G, Ritman EL, et al. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Clin Invest 1998;101:1551-1556.
28. Williams JK, Armstrong ML, Heistad DD. Vasa vasorum in atherosclerotic coronary arteries: Responses to vasoactive stimuli and regression of atherosclerosis. Circ Res 1988;62:515-523.
29. Ingber D, Fujita T, Kishimoto S, et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 1990;348:555-557.
30. Brogi E, Winkles JA, Underwood R, et al. Distinct patterns of experssion of fibroblast growth factors and their receptors in human atheroma and nonatheroselerotic arteries. J Clin Invest 1993;92:2408-2418.
31. Couffinhal T, Kearney M, Witzenbichler B, et al. VEGF(VPF) in normal and atherosclerotic human arteries. Am J Pathol 1997;150:1673-1685.
32. Waltenberger J. Modulation of growth factor action: Implications for the treatment of cardiovascular diseases. Circulation 1997;96:4083-4093.
33. Yanagisawa-Miwa A, Uchida Y, Nakamura F, et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 1992;257:1401-1403.
34. Baffour R, Berman J, Garb JL, et al. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose-response effect of basic fibroblast growth factor. J Vase Surg 1992;16:181-191.
35. Chlebourn JO, Martins RN, Mitchell CA, et al. bFGF enhances the development of the collateral circulation after acute arterial occlusion. Biochem Biophys Res Commun 1992;185:510-516.
36. Battler A, Scheinowitz M, Bor A, et al. Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium. J Am Coll Cardial 1993;22:2001-2006.
37. Harada K, Grossman W, Friedman M, et al. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest 1994;94:623-630.
38. Uchida Y, Yanagisawa-Miwa A, Ikuta M, et al. Angiogenic therapy of acute myocardial infarction (AMI) by intrapericardial injection of basic fibroblast growth factor (bFGF) and haparan sulfate (HS): An experimental study. (abstract) Circulation 1994;90:1-296.
39. Unger EF, Banai S, Shou M, et al. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 1994;35:H1588-H1595.
40. Lazarous DF, Scheinowitz M, Shou M, et al. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 1905;91:145-153.
41. Barrios V, Cuevas B, Carceller F, et al. Angiogenesis in the rat heart induced by local delivery of basic fibroblast growth factor. (abstract) Eur Heart J 1995;16:171.
42. Yang HT, Deschenes MR, Ogilvic RW, et al. Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation. Circ Res 1996;79:62-69.
43. Martins RN, Chleboun JO, Sellers P, et al. The role of PDGF-BB on the development of the collateral circulation after acute arterial occlusion. Growth Factors 1994;10:299-306.
44. Brown DM, Hong SP, Farrell CL, et al. Platelet-derived growth factor BB induces functional vascular anastomoses in vivo. Proc Natl Acad Sci U S A 1995;92:5920-5924.
45. Takeshita S, Zheng LP, Brogi E, et al. Therapeutic angiogenesis: A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 1994;93:662-670.
46. Banai S, Jaklitsch MT, Shou M, et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 1994;89:2183-2189.
47. Pearlman JD, Hibberd MG, Chuang ML, et al. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med 1995;1:1085-1089.
48. Harada K, Friedman M, Lopez JJ, et al. Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol 1997;270:H1791-H1802.